Arteriosclerosis, Vol 8, 421-428, Copyright © 1988 by American Heart Association

ARTICLES

Reduced atherogenesis in cholesterol-fed diabetic rabbits. Giant lipoproteins do not enter the arterial wall

BG Nordestgaard, S Stender and K Kjeldsen
Department of Clinical Chemistry, Rigshospitalet, University of Copenhagen, Denmark.

In cholesterol-fed rabbits, alloxan-diabetes has an anti-atherogenic effect, which is associated with severe elevation of plasma triglyceride concentrations. To study this effect, we measured lipoprotein sizes and aortic permeability coefficients for cholesteryl ester and for albumin in hypertriglyceridemic diabetic cholesterol-fed rabbits and in normotriglyceridemic cholesterol-fed rabbits. With the same high cholesterol concentration in plasma, hypertriglyceridemic diabetic rabbits had 70% of plasma cholesterol in very large lipoproteins (diameter greater than 75 nm), whereas normotriglyceridemic rabbits had only about 10% of plasma cholesterol in these giant lipoproteins. The aortic permeability coefficients for cholesteryl ester in hypertriglyceridemic diabetic cholesterol-fed rabbits was only 10% to 50% of that in normotriglyceridemic cholesterol- fed rabbits. Aortic permeability coefficients for albumin did not differ significantly between the hypertriglyceridemic and normotriglyceridemic rabbits. The results suggest that the large size of a major fraction of plasma lipoproteins in the hypertriglyceridemic diabetic cholesterol-fed rabbits is responsible for the relatively low aortic permeability coefficient for cholesteryl ester from plasma and hence for reduced atherogenesis in these animals.

This article has been cited by other articles:

				J. J. Freiberg, A. Tybjaerg-Hansen, J. S. Jensen, and B. G. Nordestgaard Nonfasting Triglycerides and Risk of Ischemic Stroke in the General Population JAMA, November 12, 2008; 300(18): 2142 - 2152. [Abstract] [Full Text] [PDF]

				B. G. Nordestgaard, M. Benn, P. Schnohr, and A. Tybjaerg-Hansen Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women JAMA, July 18, 2007; 298(3): 299 - 308. [Abstract] [Full Text] [PDF]

				W. Hsueh, E. D. Abel, J. L. Breslow, N. Maeda, R. C. Davis, E. A. Fisher, H. Dansky, D. A. McClain, R. McIndoe, M. K. Wassef, et al. Recipes for Creating Animal Models of Diabetic Cardiovascular Disease Circ. Res., May 25, 2007; 100(10): 1415 - 1427. [Abstract] [Full Text] [PDF]

				I. J. Goldberg and H. M. Dansky Diabetic Vascular Disease: An Experimental Objective Arterioscler Thromb Vasc Biol, August 1, 2006; 26(8): 1693 - 1701. [Abstract] [Full Text] [PDF]

				S. L. Karackattu, B. Trigatti, and M. Krieger Hepatic Lipase Deficiency Delays Atherosclerosis, Myocardial Infarction, and Cardiac Dysfunction and Extends Lifespan in SR-BI/Apolipoprotein E Double Knockout Mice Arterioscler Thromb Vasc Biol, March 1, 2006; 26(3): 548 - 554. [Abstract] [Full Text] [PDF]

				M.-a. Kawashiri, T. Higashikata, M. Mizuno, M. Takata, S. Katsuda, K. Miwa, T. Nozue, A. Nohara, A. Inazu, J. Kobayashi, et al. Long-Term Course of Lipoprotein Lipase (LPL) Deficiency Due to Homozygous LPLArita in a Patient with Recurrent Pancreatitis, Retained Glucose Tolerance, and Atherosclerosis J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6541 - 6544. [Abstract] [Full Text] [PDF]

				M. F. Khalil, W. D. Wagner, and I. J. Goldberg Molecular Interactions Leading to Lipoprotein Retention and the Initiation of Atherosclerosis Arterioscler Thromb Vasc Biol, December 1, 2004; 24(12): 2211 - 2218. [Abstract] [Full Text] [PDF]

				L.G Lyngdorf, S Gregersen, A Daugherty, and E Falk Paradoxical reduction of atherosclerosis in apoE-deficient mice with obesity-related type 2 diabetes Cardiovasc Res, October 1, 2003; 59(4): 854 - 862. [Abstract] [Full Text] [PDF]

				S. D. Proctor and J. C.L. Mamo Intimal Retention of Cholesterol Derived From Apolipoprotein B100- and Apolipoprotein B48-Containing Lipoproteins in Carotid Arteries of Watanabe Heritable Hyperlipidemic Rabbits Arterioscler Thromb Vasc Biol, September 1, 2003; 23(9): 1595 - 1600. [Abstract] [Full Text] [PDF]

				K. Kornerup, B. G. Nordestgaard, B. Feldt-Rasmussen, K. Borch-Johnsen, K. S. Jensen, and J. S. Jensen Transvascular Low-Density Lipoprotein Transport in Patients With Diabetes Mellitus (Type 2): A Noninvasive In Vivo Isotope Technique Arterioscler Thromb Vasc Biol, July 1, 2002; 22(7): 1168 - 1174. [Abstract] [Full Text] [PDF]

				I. J. Goldberg Diabetic Dyslipidemia: Causes and Consequences J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 965 - 971. [Full Text]

				J. D. Wagner, J. M. Cline, M. K. Shadoan, B. C. Bullock, S. E. Rankin, and W. T. Cefalu Naturally Occurring and Experimental Diabetes in Cynomolgus Monkeys: A Comparison of Carbohydrate and Lipid Metabolism and Islet Pathology Toxicol Pathol, January 1, 2001; 29(1): 142 - 148. [Abstract] [PDF]

				J. S. Jensen, B. Feldt-Rasmussen, S. Strandgaard, M. Schroll, and K. Borch-Johnsen Arterial Hypertension, Microalbuminuria, and Risk of Ischemic Heart Disease Hypertension, April 1, 2000; 35(4): 898 - 903. [Abstract] [Full Text] [PDF]

				Y. Kako, L.-S. Huang, J. Yang, T. Katopodis, R. Ramakrishnan, and I. J. Goldberg Streptozotocin-induced diabetes in human apolipoprotein B transgenic mice: effects on lipoproteins and atherosclerosis J. Lipid Res., December 1, 1999; 40(12): 2185 - 2194. [Abstract] [Full Text] [PDF]

				K. Borch-Johnsen, B. Feldt-Rasmussen, S. Strandgaard, M. Schroll, and J. S. Jensen Urinary Albumin Excretion : An Independent Predictor of Ischemic Heart Disease Arterioscler Thromb Vasc Biol, August 1, 1999; 19(8): 1992 - 1997. [Abstract] [Full Text] [PDF]

				A. M. Schmidt, S. D. Yan, J.-L. Wautier, and D. Stern Activation of Receptor for Advanced Glycation End Products : A Mechanism for Chronic Vascular Dysfunction in Diabetic Vasculopathy and Atherosclerosis Circ. Res., March 19, 1999; 84(5): 489 - 497. [Abstract] [Full Text] [PDF]

				H. Mezdour, R. Jones, C. Dengremont, G. Castro, and N. Maeda Hepatic Lipase Deficiency Increases Plasma Cholesterol but Reduces Susceptibility to Atherosclerosis in Apolipoprotein E-deficient Mice J. Biol. Chem., May 23, 1997; 272(21): 13570 - 13575. [Abstract] [Full Text] [PDF]

				J. S. Jensen Renal and Systemic Transvascular Albumin Leakage in Severe Atherosclerosis Arterioscler Thromb Vasc Biol, September 1, 1995; 15(9): 1324 - 1329. [Abstract] [Full Text]